Teratom matur ovarian bilateral asociat cu carcinosarcom -asociere întâmplãtoare sau determinism etiopatogenic? -prezentare de caz Carcinosarcomul este o forma rarã de cancer ovarian cu origine mixtã, iar asocierea sa cu teratomul matur este extrem de rarã. Prezentãm cazul pacientei T.M. în vârstã de 67 ani, internatã în clinicã în 15.05.2016, F.O. 4877 pentru creaeterea în volum a abdomenului. La internare, pacienta afebrilã, conaetientã, cooperantã, echilibratã cardio-respirator, cu abdomen destins de volum, matitate accentuatã pe flancuri, semnul valului pozitiv, bioumoral în limite normale cu excepåia: acid uric seric = 6.64 mg/dl, glicemie sericã = 113.7 mg/dl, proteine serice totale = 8.65 g/dl, raportul albuminã/globulinã subunitar, CRP 33.63 mg/l, sideremie 51 ug/dl, CA 125 = 588.4 UI. Ecografia abdominalã: cantitate mare de lichid decliv aei perihepatic aei multiple formaåiuni tumorale cu transformare chisticã la nivelul abdomenului aei pelvisului. Examen CT descrie multiple mase tisulare localizate intraperitoneal abdomino-pelvin, manaeonate în epanaeament lichidian, infiltrative, cu efect de masã pe lumenele digestive, fãrã obstrucåie vizibilã CT. Tratamentul chirurgical a constat în evacuarea lichidului de ascitã, excizia formaåiunilor tumorale din marele epiploon, a formaåiunilor tumorale din ligamentul gastro-colic, epiploonectomie, anexectomie bilateralã aei histerectomie totalã. Evoluåie postoperatorie simplã. Examenul histopatologic confirmã diagnosticul de carcinosarcom ovarian bilateral asociat cu teratom matur tridermic (prezenåa zonelor de åesut cerebral, asociat cu åesut cartilaginos, epiteliu de tip tranziåional, epiteliu de tip tubar, stromã de tip endometrial, åesut adipos). IHC confirmã compatibilitatea cu diagnosticul de carcinosarcom ovarian (tumorã malignã mixtã mullerianã). Pacienta a urmat polichimioterapie adjuvantã. Asocierea teratomului cu elemente carcinosarcomatoase conferã cazului un prognostic infaust.
Introduction Introduction
Carcinosarcoma is a rare form of ovarian cancer with epithelial origin, has a poor prognosis compared with high grade serous papillary carcinoma, regardless of the FIGP staging and its association with mature teratoma (dermoid cyst) is extremely rare as its malignancy is -in less than 2% of cases. (1) 
Case report Case report
We present the case of a patient, T 
Histopathological and immunophenotype appearance is compatible with a diagnosis of ovarian carcinosarcoma (mixed Mullerian tumor). Favorable postoperative evolution, encumbered by the appearance of a postoperative ileus treated conservatively with discharge in the 15
th postoperative day. Postoperatively, the patient was taken over by an oncologist who established adjuvant chemotherapy.
Discussions Discussions
The term of teratoma derives from the greek term of "teratos" and it means monster (1).
Teratomas are the most common germ cell tumors consisting of 2 or 3 germ foils: ectoderm, mesoderm or mature endoderm. Mature teratomas are made up of differentiated components found in adult such as cartilage or glandular epithelium while immature teratomas contain tissue with incomplete somatic differentiation similar to the fetal tissues. (2) Literature data report mature teratoma association with different types of ovarian malignancy in cases where injuries were identified strictly on the ovaries. (3) The incidence of malignant transformation in mature teratoma of the ovary is less than 2% as reported in gynaecological and pathological literature. (1) Currently, the malignant transformation of teratoma is most often postoperative diagnosed by histopathological examination of the resection specimens. (4) Incriminated predictive factors for malignant transformation of ovarian mature teratoma include high values of CA-125, older age, larger tumor and postmenopausal status. (5, 6) .
Our patient was in menopause for 17 years, the abdominopelvic tumor formations were between 0.5-20 cm, and CA-125 level was increased about 20 times. Similar data we met in other studies showing that: ovarian malignant transformation of mature teratomas usually occurs in women after menopause; Tumor formation is characterized by large (greater than 10 cm diameter) and presenting high level of serum CA-125. (7, 8, 9, 10, 11, 12, 13) Moreover, in the case presented, the presence of multiple masses of tissue located intraperitoneal belled in fluid effusion, infiltrative raised a high suspicion of a neoplastic process with adnexal starting point but the presence of mature teratoma aspects was a histopathological surprise.
Studies in the literature reveal that, most often degeneration is of squamous cell carcinoma type (88.3%), followed by adenocarcinoma, fibrosarcoma, carcinoid and mixed tumors. (14) In our patient, the mature teratoma degenerationa was of carcinosarcoma type. In the cases of tumors located strictly in the ovaries the therapeutic attitude is represented by anexectomy followed by complete resection after histopathological confirmation of malignant mature teratoma. (15) Literature data show that patients with ovarian carcinosarcoma tumors seek medical attention in advanced stages of the disease in 90% of the cases, in most cases the tumors exceeds the ovary and is accompanied by the presence of ascites. (16) If the studied case, the clinical and laboratory investigations have confirmed the presence of abdominopelvic mixed, bulky tumor formation, probably with ovarian starting point and a large amount of ascites.
In the case of ovarian carcinosarcoma diagnosed in advanced stages debulking is first intended, followed by adjunvant chemotherapy.
Our therapeutic strategy consisted in applying the surgical treatment as the first therapeutic sequence -due to biological conditions and absence of metastatic determinations, followed by adjuvant chemotherapy.
Currently, the literature and reported cases are in small numbers and because of this therapeutic strategy is not fully established. The literature suggests that the optimal treatment for carcinosarcoma consists of surgical debulking and chemotherapy. Given that on admission the patient had a good clinical and biological condition, the surgical treatment is first recommended followed by adjuvant chemotherapy. In patients with poor clinical and biological condition chemotherapy is first recommended, possibly with neoadjuvant character, given that the tumor is responsive to treatment. (17) Because of the small number of cases there is no standard chemotherapy scheme. (18) Many authors include platinium salts in their chemotherapy schemes. (19, 20) In our case, from the HP point of view, the elements of mature teratoma were supported by the presence in the excised tumor formations of brain tissue associated with cartilage, transitional type epithelium, tubal type epithelium, endometrial type stroma and fatty tissue. Literature data suggest that the presence of brain tissue in mature teratoma is rare. (21, 22, 23) Although the HP appearance was highly suggestive for the diagnosis of carcinosarcoma associated with mature teratoma, we performed immunohistochemical testing for confirmation of the mixed character of the malignant proliferation (for the carcinomatous component AE1 / AE3, CA-125, ER, WT1, Although we have no data to prove the existence of a previously asymptomatic ovarian mature teratoma we believe that the coexistence of mature teratoma elements with malignant ones in the peritoneal and ovarian tumor formations support the diagnosis of malignant mature teratoma.
Sarcomatous component association confers a poor prognosis case.
Conclusions Conclusions
Carcinosarcoma developed on ovarian mature teratoma is rare and surprising.
Therefore, there is no standard of therapy, in most cases being executed the surgery followed by chemotherapy.
